This review provides an update on new generation transcatheter heart valves and delivery systems developed to minimize procedural complications and improve patient outcomes in aortic valve disease.
This review provides an update on the development and features of next-generation transcatheter heart valves and delivery systems for aortic valve disease.
Over the last 15 years, the management of aortic valve disease has been changed by transcatheter aortic valve replacement, which has become the standard of care across the entire spectrum of surgical risk. As a result of continuous evolution of this technique, several next-generation transcatheter heart valves (THVs) have been developed to minimize procedural complications and improve patient outcomes. This review aims to provide an update on the new generation THVs and delivery systems.
Santangelo et al. (Wed,) conducted a review in Aortic valve disease. New generation transcatheter heart valves (THVs) and delivery systems was evaluated. This review provides an update on new generation transcatheter heart valves and delivery systems developed to minimize procedural complications and improve patient outcomes in aortic valve disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: